Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 02, 2025 08:05 ET | Source: Nutriband Inc.

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

Stock dividend
July 01, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

NTRB Added to 4 Russell Indexes
June 24, 2025 09:00 ET | Source: Interlink Electronics, Inc.

Interlink Electronics to Highlight Printed Sensor Advances for Wearables at Sensors Converge 2025

FREMONT, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Interlink Electronics, Inc. (Nasdaq: LINK), a world-leading provider of sensors and printed electronics solutions that support a wide range of...
June 18, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Commercial Scale up complete for AVERSA
June 09, 2025 07:30 ET | Source: Nutriband Inc.

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

New Patent issuance
June 03, 2025 08:00 ET | Source: Nutriband Inc.

Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference

noble conference announcement
June 02, 2025 08:00 ET | Source: Nutriband Inc.

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Q1 results
May 30, 2025 16:15 ET | Source: Plus Therapeutics Inc.

Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights

Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights
May 20, 2025 08:29 ET | Source: NovelStem International Corp.

NovelStem Announces Material Developments and Strategic Repositioning of the Company

$NSTM: NovelStem Announces Material Developments and Strategic Repositioning of the Company.
May 15, 2025 16:15 ET | Source: BIO-key International, Inc.

BIO-key Reports Q1’25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET

BIO-key (Nasdaq: BKYI) Reports Q1’25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET.

Next Page keyboard_arrow_right